Article Text
Statistics from Altmetric.com
Key learning points
The Medicines and Healthcare products Regulatory Agency (MHRA) has published two safety updates on fluoroquinolone antibiotics.
The MHRA continues to receive reports of adverse events with fluoroquinolones including one death by suicide thought to be related to ciprofloxacin.
Fluoroquinolones should not be prescribed for non-severe or self-limiting infections and used cautiously in people in at-risk groups.
All patients, but especially those with existing mental health issues, should be made aware of the risk of new or worsening psychiatric symptoms associated with fluoroquinolones.
The Medicines and Healthcare products Regulatory Agency has issued two updates about serious safety issues associated with systemic fluoroquinolone antibiotics.1 2
Overview
In 2019, restrictions on the use of fluoroquinolone antibiotics were introduced because …
Footnotes
Contributors DTB Team.
Provenance and peer review Commissioned; internally peer reviewed.